Golden Biotech Signs the Definitive Licensing Agreement with BNC Korea for the Development of Antroquinonol in COVID-19

GoldenBiotech Received FDA AoR of its Pre-EUA Meeting Request for COVID-19 Trial Drug Antroquinonol

FDA Approves GoldenBiotech's IND Application of Antroquinonol for Phase II Trial on Relapsed Acute Myeloid Leukemia (AML)